Antiangiogenic phytochemicals and medicinal herbs

Phytotherapy Research

Volumn 25, Issue 1, 2011, Pages 1-10

  Jeong, Soo Jin ^a   Koh, Wonil ^a   Lee, Eun Ok ^a   Lee, Hyo Jung ^a   Lee, Hyo Jeong ^a   Bae, Hyunsu ^a   Lü, Junxuan ^b   Kim, Sung Hoon ^a  

^a Kyung Hee University   (South Korea)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

angiogenic diseases; antiangiogenesis; medical herbs; phytochemicals; VEGF VEGFR

Indexed keywords

ANGIOSTATIN; ANTIRHEUMATIC AGENT; APIGENIN; BEVACIZUMAB; CAFFEIC ACID; CAMPESTEROL; CELASTROL; COUMARIN DERIVATIVE; CURCUMIN; DELPHINIDIN; ELLAGIC ACID; ENDOSTATIN; EPIGALLOCATECHIN GALLATE; FARNESIFEROL C; FISETIN; FLAVONE; GALLIC ACID; GENISTEIN; GUGGULSTERONE; HYPERICIN; PAEONIFLORIN; PLANT MEDICINAL PRODUCT; QUERCETIN; RESVERATROL; SCOPOLIN; SOLIMASTAT; SULFORAPHANE; TANNIN; THYMOQUINONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIANGIOGENIC ACTIVITY; CLINICAL TRIAL; DIABETIC RETINOPATHY; DRUG MECHANISM; DRUG SCREENING; ENDOMETRIOSIS; HERB; HUMAN; INFLAMMATION; METASTASIS; NEOPLASM; NONHUMAN; OBESITY; REVIEW; RHEUMATOID ARTHRITIS;

ANGIOGENESIS INHIBITORS; ANIMALS; DIABETIC RETINOPATHY; ENDOMETRIOSIS; FEMALE; HUMANS; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OBESITY; PHYTOTHERAPY; PLANTS, MEDICINAL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78650673039     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3224     Document Type: Review

References (130)

1. Arbiser JL., 2007. Why targeted therapy hasn't worked in advanced cancer. J Clin Invest 117: 2762-2765.
2. Barthomeuf C., 2007. Inhibition of S1P-induced angiogenesis, metastasis and inflammation by dietary polyphenols. Free Radic Biol Med 42: 312-313.
3. Becker CM, D'Amato RJ., 2007. Angiogenesis and antiangiogenic therapy in endometriosis. Microvasc Res 74: 121-130.
4. Bergers G, Benjamin LE., 2003. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3: 401-410.
5. Bernatchez PN, Soker S, Sirois MG., 1999. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent. J Biol Chem 274: 31047-31054.
6. Bertelli AA, Baccalini R, Battaglia E, Falchi M, Ferrero ME., 2001. Resveratrol inhibits TNF alpha-induced endothelial cell activation. Therapie 56: 613-616.
7. Binion DG, Otterson MF, Rafiee P., 2008. Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. Gut 57: 1509-1517.
8. Bishayee A., 2009. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res (Phila Pa) 2: 409-418.
9. Bos R, van Diest PJ, de Jong JS, Van der Groep P, Van Der Valk P, Van Der Wall E., 2005. Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 46: 31-36.
10. Büchler P, Reber HA, Buchler MW, Friess H, Lavey RS, Hines OJ., 2004. Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression. Cancer 100: 201-210.
11. Bussolino F, Mantovani A, Persico G., 1997. Molecular mechanisms of blood vessel formation. Trends Biochem Sci 22: 251-256.
12. Carmeliet P., 2003. Angiogenesis in health and disease. Nat Med 9: 653-660.
13. Carmeliet P, Jain RK., 2000. Angiogenesis in cancer and other diseases. Nature 407: 249-257.
14. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB., 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 47: 943-946. (Pubitemid 17027906)
15. Chen JC, Chen Y, Lin JH, Wu JM, Tseng SH., 2006. Resveratrol suppresses angiogenesis in gliomas: evaluation by color Doppler ultrasound. Anticancer Res 26: 1237-1245.
16. Chen Y, Li XX, Xing NZ, Cao XG., 2008. Quercetin inhibits choroidal and retinal angiogenesis in vitro. Graefes Arch Clin Exp Ophthalmol 246: 373-378.
17. Chen Y, Zhang YX, Li MH, et al,. 2005. Antiangiogenic activity of 11,11′-dideoxyverticillin, a natural product isolated from the fungus Shiraia bambusicola. Biochem Biophys Res Commun 329: 1334-1342.
18. Choi JM, Lee EO, Lee HJ, et al,. 2007. Identification of campesterol from Chrysanthemum coronarium L. and its antiangiogenic activities. Phytother Res 21: 954-959.
19. Christiaens V, Lijnen HR., 2006. Role of the fibrinolytic and matrix metalloproteinase systems in development of adipose tissue. Arch Physiol Biochem 112: 254-259.
20. Dell'Aica I, Niero R, Piazza F, et al,. 2007. Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis. J Pharmacol Exp Ther 321: 492-500.
21. Deng R., 2007. Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits. Cardiovasc Drug Rev 25: 375-390.
22. Dona M, Dell'Aica I, Calabrese F, et al,. 2003. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J Immunol 170: 4335-4341.
23. Ejaz A, Wu D, Kwan P, Meydani M., 2009. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr 139: 919-925.
24. Ellis LM, Hicklin DJ., 2008. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer 8: 579-591.
25. Feghali CA, Wright TM., 1997. Cytokines in acute and chronic inflammation. Front Biosci 2: d12-d26.
26. Feldmann M., 1996. What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis? Int Arch Allergy Immunol 111: 362-365.
27. Ferrara N, Davis-Smyth T., 1997. The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25.
28. Firestein GS., 2003. Evolving concepts of rheumatoid arthritis. Nature 423: 356-361.
29. Fischer C, Mazzone M, Jonckx B, Carmeliet P., 2008. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer 8: 942-956.
30. Folkman J., 1984. What is the role of endothelial cells in angiogenesis? Lab Invest 51: 601-604.
31. Furumatsu T, Yamaguchi N, Nishida K, et al,. 2002. Endostatin inhibits adhesion of endothelial cells to collagen I via alpha(2)beta(1) integrin, a possible cause of prevention of chondrosarcoma growth. J Biochem 131: 619-626.
32. Glade Bender J, Cooney EM, Kandel JJ, Yamashiro DJ., 2004. Vascular remodeling and clinical resistance to antiangiogenic cancer therapy. Drug Resist Updat 7: 289-300.
33. Gong YQ, Fan Y, Wu DZ, Yang H, Hu ZB, Wang ZT., 2004. In vivo and in vitro evaluation of erianin, a novel anti-angiogenic agent. Eur J Cancer 40: 1554-1565.
34. Gonzalez-Ramos R, Van Langendonckt A, Defrere S, et al,. 2008. Agents blocking the nuclear factor-kappaB pathway are effective inhibitors of endometriosis in an in vivo experimental model. Gynecol Obstet Invest 65: 174-186.
35. Gordon JD, Shifren JL, Foulk RA, Taylor RN, Jaffe RB., 1995. Angiogenesis in the human female reproductive tract. Obstet Gynecol Surv 50: 688-697.
36. Grant DS, Kinsella JL, Fridman R, et al,. 1992. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J Cell Physiol 153: 614-625.
37. Griffioen AW, Molema G., 2000. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52: 237-268.
38. Groothuis PG, Nap AW, Winterhager E, Grummer R., 2005. Vascular development in endometriosis. Angiogenesis 8: 147-156.
39. Harris ED Jr,. 1994. Rheumatoid arthritis. Curr Opin Rheumatol 6: 287-289.
40. Hattori K, Dias S, Heissig B, et al,. 2001. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 193: 1005-1014.
41. He R, Liu B, Yang C, Yang RC, Tobelem G, Han ZC., 2003. Inhibition of K562 leukemia angiogenesis and growth by expression of antisense vascular endothelial growth factor (VEGF) sequence. Cancer Gene Ther 10: 879-886.
42. Higuchi A, Yamada H, Yamada E, Jo N, Matsumura M., 2008. Hypericin inhibits pathological retinal neovascularization in a mouse model of oxygen-induced retinopathy. Mol Vis 14: 249-254.
43. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA., 2004. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56: 549-580.
44. Hu H, Lee HJ, Jiang C, et al,. 2008. Penta-1,2,3,4,6-O-galloyl-beta-D- glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo. Mol Cancer Ther 7: 2681-2691.
45. Hu H, Zhang J, Lee HJ, Kim SH, Lu J., 2009. Penta-O-galloyl-beta-D- glucose induces S- and G(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1. Carcinogenesis 30: 818-823.
46. Huang Y, Zhou Y, Fan Y, Zhou D., 2008. Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expression. Cancer Lett 264: 101-106.
47. Huang YL, Zhou YX, Zhou D, et al,. 2003. [Celastrol in the inhibition of neovascularization]. Zhonghua Zhong Liu Za Zhi 25: 429-432.
48. Huh JE, Lee EO, Kim MS, et al,. 2005. Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways. Carcinogenesis 26: 1436-1445.
49. Ichinose K, Maeshima Y, Yamamoto Y, et al,. 2006. 2-(8-Hydroxy-6-methoxy- 1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice. Diabetes 55: 1232-1242.
50. Jackson JK, Higo T, Hunter WL, Burt HM., 2006. The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflamm Res 55: 168-175.
51. Jackson SJ, Singletary KW, Venema RC., 2007. Sulforaphane suppresses angiogenesis and disrupts endothelial mitotic progression and microtubule polymerization. Vascul Pharmcol 46: 77-84.
52. Jaffe EA, Nachman RL, Becker CG, Minick CR., 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745-2756.
53. Jardeleza MS, Miller JW., 2009. Review of anti-VEGF therapy in proliferative diabetic retinopathy. Semin Ophthalmol 24: 87-92.
54. Jeon KS, Na HJ, Kim YM, Kwon HJ., 2005. Antiangiogenic activity of 4-O-methylgallic acid from Canavalia gladiata, a dietary legume. Biochem Biophys Res Commun 330: 1268-1274.
55. Jost LM, Kirkwood JM, Whiteside TL., 1992. Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. J Immunol Methods 147: 153-165.
56. Joussen AM, Rohrschneider K, Reichling J, Kirchhof B, Kruse FE., 2000. Treatment of corneal neovascularization with dietary isoflavonoids and flavonoids. Exp Eye Res 71: 483-487.
57. Jung MH, Lee SH, Ahn EM, Lee YM., 2009. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway. Carcinogenesis 30: 655-661.
58. Kamiyama H, Kakeya H, Usui T, et al,. 2008. Epoxyquinol B shows antiangiogenic and antitumor effects by inhibiting VEGFR2, EGFR, FGFR, and PDGFR. Oncol Res 17: 11-21.
59. Katoh O, Tauchi H, Kawaishi K, Kimura A, Satow Y., 1995. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res 55: 5687-5692.
60. Keck PJ, Hauser SD, Krivi G, et al,. 1989. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246: 1309-1312.
61. Kim JH, Lee BJ, Kim JH, et al,. 2009a. Rosmarinic acid suppresses retinal neovascularization via cell cycle arrest with increase of p21(WAF1) expression. Eur J Pharmacol 615: 150-154.
62. Kim KS, Yu JH, Kim YB, Kim SH., 2009b. Bojungbangdocktang inhibits vascular endothelial growth factor induced angiogenesis via blocking the VEGF/VEGFR2 signaling pathway in human umbilical vein endothelial cells. Chin Sci Bull 54: 227-233.
63. Kim SA, Lee HJ, Ahn KS, et al,. 2009c. Paeonol exerts anti-angiogenic and anti-metastatic activities through downmodulation of Akt activation and inactivation of matrix metalloproteinases. Biol Pharm Bull 32: 1142-1147.
64. Kim SH, Lee TH, Yang DC, et al,. 2005. Shiquandabutangjiaweibang inhibits tumor metastasis and angiogenesis via regulation of topoisomerase-1. J Ethnopharmacol 98: 157-162.
65. Koch AE, Kunkel SL, Harlow LA, et al,. 1992. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 90: 772-779.
66. Krupinski J, Font A, Luque A, Turu M, Slevin M., 2008. Angiogenesis and inflammation in carotid atherosclerosis. Front Biosci 13: 6472-6482.
67. Kunnumakkara AB, Anand P, Aggarwal BB., 2008. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269: 199-225.
68. Labrecque L, Lamy S, Chapus A, et al,. 2005. Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound. Carcinogenesis 26: 821-826.
69. Lamy S, Beaulieu E, Labbe D, et al,. 2008. Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling. Carcinogenesis 29: 1033-1041.
70. Laschke MW, Schwender S, Scheuer C, Vollmar B, Menger MD., 2008. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Hum Reprod 23: 2308-2318.
71. Laschke MW, Schwender S, Scheuer C, Vollmar B, Menger MD., 2008. Dietary glycine does not affect physiological angiogenesis and reproductive function, but inhibits apoptosis in endometrial and ovarian tissue by down-regulation of nuclear factor-kappaB. Fertil Steril 90 (4 Suppl): 1460-1469.
72. Lee EO, Lee HJ, Hwang HS, et al,. 2006a. Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities. Carcinogenesis 27: 2059-2069.
73. Lee HJ, Lee EO, Lee JH, et al,. 2009a. In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin. Am J Chin Med 37: 127-142.
74. Lee HJ, Lee EO, Rhee YH, et al,. 2006b. An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogenesis, apoptosis and metastasis. Carcinogenesis 27: 2455-2463.
75. Lee HJ, Magesh V, Nam D, et al,. 2008. Shikonin, acetylshikonin, and isobutyroylshikonin inhibit VEGF-induced angiogenesis and suppress tumor growth in Lewis lung carcinoma-bearing mice. Yakugaku Zasshi 128: 1681-1688.
76. Lee HJ, Song GY, Li G, Lee JH, Lu J, Kim SH., 2007. 6-(1-Oxobutyl)-5,8- dimethoxy-1,4-naphthoquinone inhibits Lewis lung cancer by antiangiogenesis and apoptosis. Int J Cancer 120: 2481-2490.
77. Lee JD, Huh JE, Jeon G, et al,. 2009b. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. Int Immunopharmacol 9: 268-276.
78. Lee JH, Choi S, Lee Y, et al,. 2010. Herbal compound farnesiferol C exerts antiangiogenic and antitumor activity and targets multiple aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) signaling cascades. Mol Cancer Ther 9: 389-399.
79. Lee KG, Shibamoto T, Takeoka GR, Lee SE, Kim JH, Park BS., 2003. Inhibitory effects of plant-derived flavonoids and phenolic acids on malonaldehyde formation from ethyl arachidonate. J Agric Food Chem 51: 7203-7207.
80. Lee SJ, Lee HM, Ji ST, Lee SR, Mar W, Gho YS., 2004. 1,2,3,4,6-Penta-O- galloyl-beta-D-glucose blocks endothelial cell growth and tube formation through inhibition of VEGF binding to VEGF receptor. Cancer Lett 208: 89-94.
81. Letilovic T, Vrhovac R, Verstovsek S, Jaksic B, Ferrajoli A., 2006. Role of angiogenesis in chronic lymphocytic leukemia. Cancer 107: 925-934. (Pubitemid 44291140)
82. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N., 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309.
83. Lijnen HR., 2008. Angiogenesis and obesity. Cardiovasc Res 78: 286-293.
84. Lin YG, Kunnumakkara AB, Nair A, et al,. 2007. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res 13: 3423-3430.
85. Liu L, Meydani M., 2003. Angiogenesis inhibitors may regulate adiposity. Nutr Rev 61: 384-387.
86. Liu LZ, Fang J, Zhou Q, Hu X, Shi X, Jiang BH., 2005. Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer. Mol Pharmacol 68: 635-643.
87. Liu MB, He YL, Zhong J., 2009. [Small interference RNA targeting nuclear factor-kappaB inhibits endometriotic angiogenesis in chick embryo chorioallantocic membrane]. Nan Fang Yi Ke Da Xue Xue Bao 29: 757-759.
88. Liu Z, Schwimer J, Liu D, et al,. 2006. Gallic acid is partially responsible for the antiangiogenic activities of Rubus leaf extract. Phytother Res 20: 806-813.
89. Loutrari H, Magkouta S, Pyriochou A, et al,. 2006. Mastic oil from Pistacia lentiscus var. chia inhibits growth and survival of human K562 leukemia cells and attenuates angiogenesis. Nutr Cancer 55: 86-93.
90. Mahapatra NR., 2008. Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure. Cardiovasc Res 80: 330-338.
91. Martinez-Poveda B, Quesada AR, Medina MA., 2005. Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process. Int J Cancer 117: 775-780.
92. Maruotti N, Cantatore FP, Crivellato E, Vacca A, Ribatti D., 2006. Angiogenesis in rheumatoid arthritis. Histol Histopathol 21: 557-566.
93. Mu P, Gao X, Jia ZJ, Zheng RL., 2008. Natural antioxidant pedicularioside G inhibits angiogenesis and tumourigenesis in vitro and in vivo. Basic Clin Pharmacol Toxicol 102: 30-34.
94. Pan R, Dai Y, Gao X, Xia Y., 2009. Scopolin isolated from Erycibe obtusifolia Benth stems suppresses adjuvant-induced rat arthritis by inhibiting inflammation and angiogenesis. Int Immunopharmacol 9: 859-869.
95. Pang X, Yi T, Yi Z, et al,. 2009. Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways. Cancer Res 69: 518-525.
96. Passaniti A., 1992. Extracellular matrix-cell interactions: Matrigel and complex cellular pattern formation. Lab Invest 67: 804; author reply 804- 808.
97. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J., 1997. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 150: 815-821.
98. Pyun BJ, Choi S, Lee Y, et al,. 2008. Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity. Cancer Res 68: 227-235.
99. Risau W., 1997. Mechanisms of angiogenesis. Nature 386: 671-674.
100. Runkel S, Hunter N, Milas L., 1991. An intradermal assay for quantification and kinetics studies of tumor angiogenesis in mice. Radiat Res 126: 237-243.
101. Rupnick MA, Panigrahy D, Zhang CY, et al,. 2002. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 99: 10730-10735.
102. Schoettler N, Brahn E., 2009. Angiogenesis inhibitors for the treatment of chronic autoimmune inflammatory arthritis. Curr Opin Investig Drugs 10: 425-433.
103. Schuch G, Oliveira-Ferrer L, Loges S, et al,. 2005. Antiangiogenic treatment with endostatin inhibits progression of AML in vivo. Leukemia 19: 1312-1317.
104. Shishodia S, Harikumar KB, Dass S, Ramawat KG, Aggarwal BB., 2008. The guggul for chronic diseases: ancient medicine, modern targets. Anticancer Res 28: 3647-3664.
105. Silvan AM, Abad MJ, Bermejo P, Sollhuber M, Villar A., 1996. Antiinflammatory activity of coumarins from Santolina oblongifolia. J Nat Prod 59: 1183-1185. (Pubitemid 27026586)
106. Son SH, Kim MJ, Chung WY, et al,. 2009. Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase. Cancer Lett 280: 86-92.
107. Stetler-Stevenson WG., 1999. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest 103: 1237-1241.
108. Straight AM, Oakley K, Moores R, et al,. 2006. Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes. Cancer Chemother Pharmacol 57: 7-14.
109. Swarnakar S, Paul S., 2009. Curcumin arrests endometriosis by downregulation of matrix metalloproteinase-9 activity. Indian J Biochem Biophys 46: 59-65.
110. Takahashi T, Shibuya M., 1997. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene 14: 2079-2089.
111. Taylor RN, Yu J, Torres PB, et al,. 2009. Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci 16: 140-146.
112. Thippeswamy G, Sheela ML, Salimath BP., 2008. Octacosanol isolated from Tinospora cordifolia downregulates VEGF gene expression by inhibiting nuclear translocation of NF-κB and its DNA binding activity. Eur J Pharmacol 588: 141-150.
113. Tong Y, Zhang X, Tian F, et al,. 2005. Philinopside A, a novel marine-derived compound possessing dual anti-angiogenic and anti-tumor effects. Int J Cancer 114: 843-853.
114. Tong Y, Zhang X, Zhao W, et al,. 2004. Anti-angiogenic effects of Shiraiachrome A, a compound isolated from a Chinese folk medicine used to treat rheumatoid arthritis. Eur J Pharmacol 494: 101-109.
115. Tsuzuki Y, Fukumura D, Oosthuyse B, Koike C, Carmeliet P, Jain RK., 2000. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1α hypoxia response element- VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res 60: 6248-6252.
116. Wagner AD, Arnold D, Grothey AA, Haerting J, Unverzagt S., 2009. Anti-angiogenic therapies for metastatic colorectal cancer. Cochrane Database Syst Rev CD005392.
117. Wang B, Zou Y, Li H, Yan H, Pan JS, Yuan ZL., 2005. Genistein inhibited retinal neovascularization and expression of vascular endothelial growth factor and hypoxia inducible factor 1alpha in a mouse model of oxygen-induced retinopathy. J Ocul Pharmacol Ther 21: 107-113.
118. Wang JY, Jin Y, Xu ZY, Zheng Z., 2009. Effects of Feiyanning decoction on gene expression of nuclear factor-kappaB activated by tumor necrosis factor-alpha in lung adenocarcinoma cell line. Zhong Xi Yi Jie He Xue Bao 7: 249-254.
119. Wary KK, Thakker GD, Humtsoe JO, Yang J., 2003. Analysis of VEGF-responsive genes involved in the activation of endothelial cells. Mol Cancer 2: 25.
120. Xiao Z, Wang Y, Lu L, et al,. 2006. Anti-angiogenesis effects of meisoindigo on chronic myelogenous leukemia in vitro. Leuk Res 30: 54-59.
121. Xu H, Lui WT, Chu CY, Ng PS, Wang CC, Rogers MS., 2009. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. Hum Reprod 24: 608-618.
122. Xu WL, Shen HL, Yuan W, Wang FC, Jiang YW., 2006. [Inhibition of K562 cell growth and tumor angiogenesis in nude mice by transfection of anti-VEGF hairpin ribozyme gene into the cells]. Zhonghua Xue Ye Xue Za Zhi 27: 465-469.
123. Yao H, Wang H, Zhang Z, Jiang BH, Luo J, Shi X., 2008. Sulforaphane inhibited expression of hypoxia-inducible factor-1alpha in human tongue squamous cancer cells and prostate cancer cells. Int J Cancer 123: 1255-1261.
124. Yi T, Cho SG, Yi Z, et al,. 2008a. Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol Cancer Ther 7: 1789-1796.
125. Yi T, Yi Z, Cho SG, et al,. 2008b. Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. Cancer Res 68: 1843-1850.
126. Zhang J, Li L, Kim SH, Hagerman AE, Lu J., 2009. Anti-cancer, anti-diabetic and other pharmacologic and biological activities of penta-galloyl-glucose. Pharm Res 26: 2066-2080.
127. Zhang M, Xu ZY, Bai B, Dong Y., 2008. [Feiyanning decoction down-regulates the expressions of phosphorylated Akt and hypoxia inducible factor-1alpha proteins in transplanted lung adenocarcinoma in nude mice]. Zhong Xi Yi Jie He Xue Bao 6: 616-620.
128. Zhang X, Lawler J., 2007. Thrombospondin-based antiangiogenic therapy. Microvasc Res 74: 90-99.
129. Zheng YQ, Wei W, Zhu L, Liu JX., 2007. Effects and mechanisms of Paeoniflorin, a bioactive glucoside from paeony root, on adjuvant arthritis in rats. Inflamm Res 56: 182-188. (Pubitemid 46985833)
130. Zhou HJ, Wang WQ, Wu GD, Lee J, Li A., 2007. Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells. Vascul Pharmacol 47: 131-138.